It has been proposed that the fusion proteins produced upon translocation of the human MOZ locus with other HAT-encoding genes, such as CBP or p300, support the development of leukemia by altering the regulation of MOZ transcriptional targets. This evidence concerns the gene KAT6A and leukemia.